| Literature DB >> 9255151 |
A M el-Shirbiny1, H Yeung, M Imbriaco, J Michaeli, H Macapinlac, S M Larson.
Abstract
Experience of scintigraphic detection of bone lesion and active bone marrow involvement of multiple myeloma, especially with sestamibi and FDG-PET scans is in evolution. We report a case of intense sestamibi uptake in bone marrow correlating with the extent of the disease, while FDG-PET scans showed activity only in areas of active disease progression associated with pain. Technetium-99m-sestamibi appears to indicate the extent of the disease, while [18F]FDG-PET scans show sites of active tumor proliferation and may be useful in directing local therapy such as radiation.Entities:
Mesh：
Substances：
Year: 1997 PMID： 9255151
Source DB: PubMed Journal: J Nucl Med ISSN： 0161-5505 Impact factor: 10.057